Africa Anticancer Drugs Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Africa Anticancer Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Immunotherapy Drugs, Gene Therapy Drugs, Radiopharmaceuticals, and Others), Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostrate Cancer, and Others), Dosage Form (Tablet and Capsule, Injectable, and Liquid), Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Gene Therapy, Radiopharmaceutical Therapy, and Others), Sector (Private and Public), and Country
- Status : Published
- Report Code : TIPRE00040929
- Category : Life Sciences
- No. of Pages : 315
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The anticancer drugs market majorly consists of the players such Amgen Inc, Gilead Sciences Inc, Novartis AG, F. Hoffmann-La Roche Ltd, BeiGene Ltd, Takeda Pharmaceutical Co Ltd, GSK Plc, Sanofi SA, Cipla Ltd, Johnson & Johnson, Aspen Holdings, Pfizer Inc, AstraZeneca Plc, Merck & Co Inc, and Daiichi Sankyo Co Ltd.
Based on drug class, the Africa anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, hormonal drugs, immunotherapy drugs, gene therapy drugs, radiopharmaceuticals, and others. The cytotoxic drugs segment held the largest market share in 2024.
By indication, the market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, and others. The lung cancer segment held the largest share of the market in 2024.
In terms of therapy type, the market is segmented into chemotherapy, targeted therapy, immunotherapy, gene therapy, radiopharmaceutical therapy, and others. The chemotherapy segment held the largest market share in 2024.
Anticancer drugs are the medications used for the treatment of different cancer by controlling the growth and spread of cancer cells in the body. They work by either killing cancer cells directly or preventing them from multiplying. Unlike regular cells, cancer cells divide uncontrollably and can spread to other parts of the body. Anticancer drugs target these abnormal cells while trying to minimize damage to normal cells. There are many types of anticancer drugs, each working in different ways to attack cancer. Some damage the cancer cells’ DNA, some block the nutrients they need, and others help the immune system fight cancer.
The South Africa has dominated the anticancer drugs market owing to affordability, access, and health system inequality shape the adoption of anticancer drugs in South Africa which is expected to fuel the Africa anticancer drugs market by 2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. African Anticancer Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Cancer Prevalence, By Country
4.4 Cancer Therapeutics: Pricing Analysis, 2024
4.5 Import-export Scenario in Africa
4.6 Ecosystem Analysis
4.6.1 List of Vendors in the Value Chain
5. African Anticancer Drugs Market – Key Market Dynamics
5.1 African Anticancer Drugs Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Cancer Incidence
5.2.2 Increasing Initiatives to Improve Cancer Awareness
5.3 Market Restraints
5.3.1 Unaffordability and Limited Availability of Cancer Drugs
5.4 Market Opportunities
5.4.1 Surging Number of Clinical Trials
5.5 Future Trends
5.5.1 Artificial Intelligence Accelerating Cancer Care
5.6 Impact of Drivers and Restraints:
6. African Anticancer Drugs Market – Global Market Analysis
6.1 African Anticancer Drugs Market Revenue (US$ Million), 2021–2031
6.2 African Anticancer Drugs Market Forecast Analysis
7. African Anticancer Drugs Market Analysis – by Drug Class Type
7.1 Cytotoxic Drugs
7.1.1 Overview
7.1.2 Cytotoxic Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Targeted Drugs
7.2.1 Overview
7.2.2 Targeted Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Hormonal Drugs
7.3.1 Overview
7.3.2 Hormonal Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Immunotherapy Drugs
7.4.1 Overview
7.4.2 Immunotherapy Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Gene Therapy Drugs
7.5.1 Overview
7.5.2 Gene Therapy Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Radiopharmaceuticals
7.6.1 Overview
7.6.2 Radiopharmaceuticals: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8. African Anticancer Drugs Market Analysis – by Indication
8.1 Lung Cancer
8.1.1 Overview
8.1.2 Lung Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Stomach Cancer
8.2.1 Overview
8.2.2 Stomach Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Colorectal Cancer
8.3.1 Overview
8.3.2 Colorectal Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Breast Cancer
8.4.1 Overview
8.4.2 Breast Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Prostrate Cancer
8.5.1 Overview
8.5.2 Prostrate Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
9. African Anticancer Drugs Market Analysis – by Dosage Form
9.1 Tablet and Capsule
9.1.1 Overview
9.1.2 Tablet and Capsule: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Liquid
9.3.1 Overview
9.3.2 Liquid: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10. African Anticancer Drugs Market Analysis – by Therapy
10.1 Chemotherapy
10.1.1 Overview
10.1.2 Chemotherapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Targeted Therapy
10.2.1 Overview
10.2.2 Targeted Therapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Immunotherapy
10.3.1 Overview
10.3.2 Immunotherapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Gene Therapy
10.4.1 Overview
10.4.2 Gene Therapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Radiopharmaceutical Therapy
10.5.1 Overview
10.5.2 Radiopharmaceutical Therapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11. African Anticancer Drugs Market Analysis – by Sector
11.1 Private
11.1.1 Overview
11.1.2 Private: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Public
11.2.1 Overview
11.2.2 Public: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
12. African Anticancer Drugs Market – Geographical Analysis
12.1 Africa
12.1.1 African Anticancer Drugs Market Overview
12.1.2 African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.2.1 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Drug Class Type
12.1.2.2 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Cytotoxic Drugs
12.1.2.3 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Targeted Drugs
12.1.2.4 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Hormonal Drugs
12.1.2.5 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Indication
12.1.2.6 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Dosage Form
12.1.2.7 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Therapy
12.1.2.8 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Sector
12.1.3 African Anticancer Drugs Market – Revenue and Forecast Analysis – by Country
12.1.3.1 South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.1.1 South Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.1.2 South Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.1.3 South Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.1.4 South Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.1.5 South Africa: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.1.6 South Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.1.7 South Africa: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.1.8 South Africa: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.2 Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.2.1 Egypt: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.2.2 Egypt: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.2.3 Egypt: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.2.4 Egypt: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.2.5 Egypt: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.2.6 Egypt: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.2.7 Egypt: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.2.8 Egypt: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.3 Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.3.1 Algeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.3.2 Algeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.3.3 Algeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.3.4 Algeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.3.5 Algeria: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.3.6 Algeria: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.3.7 Algeria: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.3.8 Algeria: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.4 Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.4.1 Morocco: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.4.2 Morocco: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.4.3 Morocco: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.4.4 Morocco: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.4.5 Morocco: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.4.6 Morocco: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.4.7 Morocco: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.4.8 Morocco: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.5 Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.5.1 Tunisia: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.5.2 Tunisia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.5.3 Tunisia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.5.4 Tunisia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.5.5 Tunisia: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.5.6 Tunisia: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.5.7 Tunisia: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.5.8 Tunisia: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.6 Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.6.1 Nigeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.6.2 Nigeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.6.3 Nigeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.6.4 Nigeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.6.5 Nigeria: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.6.6 Nigeria: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.6.7 Nigeria: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.6.8 Nigeria: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.7 Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.7.1 Kenya: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.7.2 Kenya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.7.3 Kenya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.7.4 Kenya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.7.5 Kenya: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.7.6 Kenya: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.7.7 Kenya: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.7.8 Kenya: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.8 Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.8.1 Ethiopia: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.8.2 Ethiopia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.8.3 Ethiopia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.8.4 Ethiopia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.8.5 Ethiopia: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.8.6 Ethiopia: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.8.7 Ethiopia: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.8.8 Ethiopia: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.9 Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.9.1 Ghana: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.9.2 Ghana: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.9.3 Ghana: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.9.4 Ghana: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.9.5 Ghana: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.9.6 Ghana: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.9.7 Ghana: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.9.8 Ghana: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.10 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.10.1 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.10.2 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.10.3 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.10.4 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.10.5 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Indication
12.1.3.10.6 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.10.7 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.10.8 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Sector
12.1.3.11 Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.11.1 Senegal: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.11.2 Senegal: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.11.3 Senegal: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.11.4 Senegal: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.11.5 Senegal: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.11.6 Senegal: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.11.7 Senegal: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.11.8 Senegal: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.12 Libya: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.12.1 Libya: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.12.2 Libya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.12.3 Libya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.12.4 Libya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.12.5 Libya: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.12.6 Libya: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.12.7 Libya: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.12.8 Libya: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.13 Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
12.1.3.13.1 Rest of Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.13.2 Rest of Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.13.3 Rest of Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.13.4 Rest of Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.13.5 Rest of Africa: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.13.6 Rest of Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.13.7 Rest of Africa: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.13.8 Rest of Africa: African Anticancer Drugs Market Breakdown, by Sector
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Industry Landscape
14.1 Overview
14.2 Market Initiative
14.3 Partnerships and Collaborations
14.4 Other Developments
15. Company Profiles
15.1 Amgen Inc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Gilead Sciences Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Novartis AG
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 F. Hoffmann-La Roche Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 BeiGene Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Takeda Pharmaceutical Co Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 GSK Plc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Sanofi SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Cipla Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Johnson & Johnson
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Aspen Holdings
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Pfizer Inc
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 AstraZeneca Plc
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 Merck & Co Inc
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
15.15 Daiichi Sankyo Co Ltd
15.15.1 Key Facts
15.15.2 Business Description
15.15.3 Products and Services
15.15.4 Financial Overview
15.15.5 SWOT Analysis
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
List of Tables
Table 1. African Anticancer Drugs Market Segmentation
Table 2. Methodology 1 – Africa Market
Table 3. Methodology 2 – Africa Market
Table 4. Each country’s market share is determined using five weighted parameters:
Table 5. Market Issues in African Anti-Cancer Drugs Market
Table 6. Cancer Prevalence, By Country- 2023
Table 7. Cancer Therapeutics, Pricing Analysis (Price (US$/Unit)- 2023
Table 8. Import Value and Quantity of Medicinal Products by Key African Countries (2024)
Table 9. Export Value and Quantity of Medicinal Products by Key African Countries (2024)
Table 10. List of Vendors
Table 11. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million)
Table 12. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million)
Table 13. Cytotoxic Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Table 14. Cytotoxic Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Table 15. Targeted Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Table 16. Targeted Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Table 17. Hormonal Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Table 18. Hormonal Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Table 19. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Drug Class Type
Table 20. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 21. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Cytotoxic Drugs
Table 22. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 23. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Targeted Drugs
Table 24. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 25. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Hormonal Drugs
Table 26. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 27. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Indication
Table 28. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 29. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Dosage Form
Table 30. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 31. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Therapy
Table 32. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 33. African Anticancer Drugs Market – Revenue, 2021 - 2024 (US$ Million) – by Sector
Table 34. African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 35. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 36. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 37. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 38. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 39. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 40. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 41. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 42. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 43. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 44. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 45. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 46. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 47. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 48. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 49. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 50. South Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 51. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 52. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 53. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 54. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 55. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 56. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 57. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 58. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 59. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 60. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 61. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 62. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 63. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 64. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 65. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 66. Egypt: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 67. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 68. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 69. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 70. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 71. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 72. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 73. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 74. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 75. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 76. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 77. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 78. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 79. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 80. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 81. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 82. Algeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 83. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 84. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 85. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 86. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 87. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 88. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 89. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 90. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 91. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 92. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 93. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 94. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 95. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 96. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 97. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 98. Morocco: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 99. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 100. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 101. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 102. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 103. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 104. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 105. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 106. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 107. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 108. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 109. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 110. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 111. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 112. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 113. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 114. Tunisia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 115. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 116. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 117. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 118. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 119. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 120. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 121. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 122. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 123. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 124. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 125. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 126. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 127. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 128. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 129. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 130. Nigeria: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 131. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 132. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 133. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 134. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 135. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 136. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 137. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 138. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 139. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 140. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 141. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 142. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 143. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 144. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 145. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 146. Kenya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 147. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 148. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 149. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 150. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 151. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 152. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 153. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 154. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 155. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 156. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 157. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 158. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 159. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 160. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 161. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 162. Ethiopia: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 163. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 164. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 165. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 166. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 167. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 168. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 169. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 170. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 171. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 172. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 173. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 174. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 175. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 176. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 177. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 178. Ghana: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 179. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 180. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 181. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 182. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 183. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 184. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 185. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 186. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 187. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 188. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 189. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 190. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 191. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 192. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 193. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 194. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 195. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 196. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 197. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 198. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 199. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 200. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 201. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 202. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 203. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 204. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 205. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 206. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 207. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 208. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 209. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 210. Senegal: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 211. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 212. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 213. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 214. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 215. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 216. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 217. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 218. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 219. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 220. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 221. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 222. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 223. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 224. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 225. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 226. Libya: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 227. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Drug Class Type
Table 228. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Drug Class Type
Table 229. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Cytotoxic Drugs
Table 230. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Cytotoxic Drugs
Table 231. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Targeted Drugs
Table 232. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Targeted Drugs
Table 233. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Hormonal Drugs
Table 234. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Hormonal Drugs
Table 235. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Indication
Table 236. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Indication
Table 237. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Dosage Form
Table 238. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Dosage Form
Table 239. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Therapy
Table 240. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Therapy
Table 241. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2024(US$ Million) – by Sector
Table 242. Rest of Africa: African Anticancer Drugs Market – Revenue, 2025 - 2031 (US$ Million) – by Sector
Table 243. Glossary of Terms, African Anticancer Drugs Market
List of Figures
Figure 1. African Anticancer Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Ecosystem Analysis
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. African Anticancer Drugs Market Revenue (US$ Million), 2021–2031
Figure 6. African Anticancer Drugs Market Share (%) – by Drug Class Type (2024 and 2031)
Figure 7. Cytotoxic Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Targeted Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Hormonal Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Immunotherapy Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Gene Therapy Drugs: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Radiopharmaceuticals: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. African Anticancer Drugs Market Share (%) – by Indication (2024 and 2031)
Figure 15. Lung Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Stomach Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Colorectal Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Breast Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Prostrate Cancer: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. African Anticancer Drugs Market Share (%) – by Dosage Form (2024 and 2031)
Figure 22. Tablet and Capsule: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Injectable: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Liquid: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. African Anticancer Drugs Market Share (%) – by Therapy (2024 and 2031)
Figure 26. Chemotherapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Targeted Therapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Immunotherapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 29. Gene Therapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Radiopharmaceutical Therapy: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Others: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. African Anticancer Drugs Market Share (%) – by Sector (2024 and 2031)
Figure 33. Private: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 34. Public: African Anticancer Drugs Market – Revenue and Forecast to 2031 (US$ Million)
Figure 35. African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 36. African Anticancer Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. South Africa: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 38. Egypt: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 39. Algeria: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 40. Morocco: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 41. Tunisia: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 42. Nigeria: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 43. Kenya: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 44. Ethiopia: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 45. Ghana: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 46. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 47. Senegal: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 48. Libya: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 49. Rest of Africa: African Anticancer Drugs Market – Revenue, 2021 - 2031 (US$ Million)
Figure 50. Heat Map Analysis by Key Players
Figure 51. Company Positioning and Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For